Section 3: Removal of embryonic or foetal tissues or cells for scientific purposes following termination of pregnancy.

The provisions of articles R. 1232-15, R. 1232-16, R. 1232-18 to R. 1232-19 and R. 1232-21 are applicable to the removal of embryonic or foetal tissues or cells for scientific purposes referred to in article L. 1241-5.

The Director General of the Agence de la biomédecine shall forward to the Minister for Research, within the time limit laid down in Article R. 1232-18, as necessary, any information revealing that the planned research is of such a nature as to call into question compliance with ethical principles, the need for the removal or the relevance of the research.

The establishment or organisation must be able to provide the following information at any time, at the request of the Minister for Research or the Director General of the Agence de la biomédecine: 1° The nature of the tissues or cells removed and the number of samples taken ; 2° The place and date of removal; 3° Any document attesting to the existence of written consent from persons who have…

In the cases provided for in Article L. 1241-5, the Minister for Research may suspend or prohibit implementation of the protocol under the conditions described in Articles R. 1232-18 and R. 1232-22. The decision to suspend or prohibit is communicated to the Director General of the Agence de la biomédecine.